Percentage changes in LDL cholesterol, hetero-dimer PCSK9, and sortilin levels at the 8-month follow-up.
Although the reduction in LDL cholesterol levels was greater in the pitavastatin group than in the pravastatin group, no significant differences in percentage changes in hetero-dimer PCSK9 and sortilin were observed. Data are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.0001 compared with baseline.